NEW YORK , Oct. 8, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The Global Enteral Syringe Market size is estimated to grow by USD 444.7 million from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 5.83% during the forecast period. Increasing prevalence of chronic conditions is driving market growth, with a trend towards growing number of target population.
However, safety concerns related to enteral feeding poses a challenge - Key market players include Amsino International Inc., Andway Healthcare Ltd., Avanos Medical Inc.
, B.Braun SE, Baxter International Inc., Becton Dickinson and Co.
, Cardinal Health Inc., Danone SA, DMC Medical Ltd., GBUK Group Ltd, Jiangsu Caina Medical Co.
Ltd., Kentec Medical Inc., Micsafe Medical Group, Medela AG, Medicina Ltd.
, Medline Industries LP, Miktell Ltd., Terumo Corp., Thermo Fisher Scientific Inc.
, and Vygon SAS. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now Key Market Trends Fueling Growth The global enteral syringe market is experiencing growth due to the increasing prevalence of pancreatic cancer, bile duct diseases, and gallbladder-related conditions.
According to the American Cancer Society, approximately 62,210 Americans were diagnosed with pancreatic cancer by the end of 2022. Gallbladder diseases, such as gallstones and gallbladder cancer, are also common, wi.
